INVESTORS' PRESENTATION Data Management Services Check our Data Management Industry Overview Global healthcare systems have been taxed in recent years with aging populations seeking care in greater numbers. Big data and analytics have seen large increases in the market as healthcare stakeholders seek to use information to increase efficiency, lower costs, improve patient outcomes, and innovate. Frontline and independent providers have benefitted from improvements to their digital systems, but data insights are a rare commodity. Regardless of size, digitization of healthcare as global trend will encourage the usage of data analytics to improve care and allow us to compete in an intense healthcare market. Per Valuates Reports, the global healthcare analytics market was estimated be over $10 billion in 2019 and is expected to increase to over $40 billion by 2025. Through our wholly owned subsidiary, ClearMetrX, we offer data management and reporting services to support healthcare organizations. Our 340MetrX offering includes data management and TPA services for 340B Covered Entities, pharmacy analytics, and programs to manage HEDIS Quality Measures including medication adherence. These offerings address the glaring need for frontline providers to understand best practices, patient behaviors, care management processes, and the financial mechanisms driving decisions. We deliver data access and also deliver actionable insights that providers and support organizations can use to improve their practice and patient care. We believe that the key to performing data management is adopting a platform that can efficiently aggregate, index, and prepare data for pharmacy business and professional use. Through our PharmMetrX offering, we believe client pharmacies can leverage the extraction and use of data improving the quality of care for patients, while increasing the profitability of their client medical practices. We believe pharmacies, physician practices, MSOs, can benefit from our data management services in many ways: 1. Strategic Planning and Budgeting: Develop yearly strategic plans and roadmaps of financial contributions. 2. Performance Metrics: Create a dashboard of internal and external key performance metrics to manage the business. 3. Managed Care Reimbursement Profitability: Mine data to identify potential ways to increase reimbursements and boost profitability. 4. Pricing and Working Capital Strategy: Analyze millions of Rx SKUs to determine optimal prices to maximize revenue, profit, and use of working capital inventory. 5. Compliance: Perform desktop audits and analyses to address compliance trends and avoid or mitigate potential business and regulatory risks. 6. Shopper Insight: Identify insights that drive strategies for customer acquisition, retention, and optimization of best loyalty offerings. Identify best customers who can increase consumption basket size and frequency of spend. 7. Medication Management and Adherence: Develop programs and best practices to improve customer compliance and adherence, increase formulary compliance, avoid harmful drug interactions, remove duplications of therapies, avoid gaps, and lower patient overall healthcare spending. 8. Value-based Performance Tracking of patients with specific chronic conditions, medications or both: Create actionable performance reports to monitor, track, and trend pharmacy delivery of clinical services to meet payer contract and star ratings expectations. 9. Operational Optimization and Efficiency: Increase visibility into pharmacy operations and opportunities to identify and address “leakages in profitability.” Streamline operational processes to control cost and improve efficiency. ‍ Investors' Presentation Full overview of RXMD's performance DOWNLOAD NOW CONTACT US: INFO@PROGRESSIVECAREUS.COM COMPANY OVERVIEW NEWS STOCK INVESTOR'S FAQ CONTACT US PRIVACY POLICY ACCREDITED AS SEEN ON COPYRIGHT 2020 © PROGRESSIVE CARE INC. FORWARD-LOOKING STATEMENTS – CERTAINSTATEMENTS INCLUDED IN THIS PRESENTATION THAT ARE NOT HISTORICAL OR CURRENT FACTS INCLUDING, BUT NOT LIMITED TO, THOSE RELATED TO OUR FINANCIAL AND BUSINESS EXPECTATIONS AND OUTLOOK, THE IMPACT OF THE EVOLVING AND UNCERTAIN HEALTHCARE ENVIRONMENT, STRATEGY AND GROWTHDRIVERS, UTILIZATION AND PATIENT VOLUME TRENDS, REVENUE VISIBILITY, ANTICIPATEDMEMBERRENEWALS OF GPO PARTICIPATION AGREEMENTS, CROSS AND UPSELL OPPORTUNITIES, ACQUISITIONACTIVITIES AND PIPELINE, REVENUE AVAILABLE UNDER CONTRACT, PURCHASESUNDEROUR SHARE REPURCHASE PROGRAM AND THE FINANCIAL IMPACT OF SHARE REPURCHASES, TAX REFORM AND COST SAVINGS EFFORTS, POTENTIAL DIVIDEND PAYMENTS, AND2020 FINANCIALGUIDANCE AND RELATED ASSUMPTIONS ARE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE FEDERALSECURITIES LAWS. FORWARD-LOOKING STATEMENTS MAY INVOLVE KNOWNAND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT MAY CAUSE THE ACTUAL RESULTS TO BE MATERIALLY DIFFERENT FROM HISTORICAL RESULTS OR FROM ANY FUTURE RESULTS OR PROJECTIONS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. ACCORDINGLY, READERSSHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD LOOKING STATEMENTS. READERS ARE URGED TO CONSIDER STATEMENTS IN THE CONDITIONAL OR FUTURE TENSES OR THAT INCLUDE TERMS SUCH AS “BELIEVES,” “BELIEF,” “EXPECTS,” “ESTIMATES,” “INTENDS,” “ANTICIPATES” OR “PLANS”TO BEUNCERTAINAND FORWARD-LOOKING.FORWARD-LOOKING STATEMENTS MAY INCLUDE COMMENTS REGARDING THE COMPANY ’S BELIEFS AND EXPECTATIONS AS TO FUTURE EVENTS AND TRENDS AFFECTING ITS BUSINESS AND ARE NECESSARILY SUBJECT TO UNCERTAINTIES, MANY OF WHICH ARE OUTSIDE COMPANY’S CONTROL. YOU SHOULD CAREFULLY READ COMPANY’S PERIODIC AND CURRENT FILINGS WITH THE OTC MARKETS FOR MORE INFORMATION ON POTENTIAL RISKS AND OTHER FACTORS THAT COULD AFFECT THE COMPANY AND ITS FINANCIAL CONDITION OR RESULTS OF OPERATIONS. FORWARD-LOOKING STATEMENTS SPEAKONLY AS OFTHE DATE THEY ARE MADE. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS. ‍NON-GAAP FINANCIALMEASURES–THIS PRESENTATIONINCLUDES CERTAIN “NON-GAAP FINANCIAL MEASURES” AS DEFINED IN REGULATION G UNDER THE SECURITIES EXCHANGE ACT OF 1934. SCHEDULES ARE ATTACHED THAT RECONCILE THE NON-GAAP FINANCIAL MEASURES INCLUDED IN THIS PRESENTATION TO THE MOST DIRECTLY COMPARABLE FINANCIAL MEASURES CALCULATEDAND PRESENTEDIN ACCORDANCEWITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN THE UNITED STATES. YOU SHOULD CAREFULLY READ PROGRESSIVE CARE’S PERIODIC AND CURRENTFILINGS ON THE OTCQB WEBSITE FOR DEFINITIONS AND FURTHER EXPLANATION AND DISCLOSURE REGARDING OUR USE OF NON-GAAP FINANCIAL MEASURES AND SUCH FILINGS SHOULD BE READ IN CONJUNCTION WITH THIS PRESENTATION.